References
1. Talcott KE, Garg RJ, Garg SJ. Ophthalmic manifestations of leukemia. Current Opinion in Ophthalmology. 2016;27(6):545–51.
2. Yassin MA, Ata F, Mohamed SF, Alkhateeb A, Naeem U, Al-Qatami AI, et al. Ophthalmologic manifestations as the initial presentation of chronic myeloid leukemia: A Review. Survey of Ophthalmology. 2022;67(2):530–43.
3. Awuah A, Asiedu K, Adanusa M, Ntodie M, Acquah E, Kyei S. A case of leukemic retinopathy mimicking common ischemic retinopathies. Clinical Case Reports. 2015;4(2):133–7.
4. Goel N, Pangtey B, Thakar M, Raina UK, Ghosh B. Chronic myeloid leukemia presenting with bilateral central retinal vein occlusion and massive retinal infiltrates. Journal of American Association for Pediatric Ophthalmology and Strabismus. 2012;16(4):406–8.
5. Porcu P, Danielson CF, Orazi A, Heerema NA, Gabig TG, McCarthy LJ. Therapeutic leukapheresis in hyperleucocytic leukaemias: Lack of correlation between degree of cytoreduction and early mortality rate. British Journal of Haematology. 1997;98(2):433–6.
6. Almeida DRP, Chin EK, Grant LW. Chronic myelogenous leukemia presenting with bilateral optic disc neovascularization. Canadian Journal of Ophthalmology. 2014;49(3).
7. Bewersdorf, J. P., Giri, S., Tallman, M. S., Zeidan, A. M., & Stahl, M. (2020). Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia—a systematic review and meta‐analysis. Transfusion, 60(10), 2360–2369. https://doi.org/10.1111/trf.15994
8. Stahl M, Shallis RM, Wei W, Montesinos P, Lengline E, Neukirchen J, et al. Management of hyperleukocytosis and impact of leukapheresis among patients with Acute myeloid leukemia (AML) on short- and long-term clinical outcomes: A large, retrospective, Multicenter, International Study. Leukemia. 2020;34(12):3149–60.
9. Pastore F, Pastore A, Wittmann G, Hiddemann W, Spiekermann K. The role of Therapeutic Leukapheresis in hyperleukocytotic AML. PLoS ONE. 2014;9(4).
10. Godbey EA, Dalton JB, Lai G, Sanford KW, Roseff SD. First reported case of leukocytapheresis in Plasma Cell Leukemia. Transfusion. 2019;60(1):11–2.
11. Mohamed, M., Oakley, C., McEwen, F., & Connelley, G. (2015). Leucapheresis for management of retinopathy in chronic myeloid leukaemia. BMJ case reports, 2015, bcr2015212889. https://doi.org/10.1136/bcr-2015-212889
12. Padmanabhan A, Connelly‐Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, et al. Guidelines on the use of therapeutic apheresis in clinical practice – evidence‐based approach from the Writing Committee of the American Society for Apheresis: The eighth special issue. Journal of Clinical Apheresis. 2019;34(3):171–354.